Day 1 :
Keynote: Peripheral Refraction-Yes or No!
Time : 09:35-10:00
Peripheral Refraction-Yes or No!
It is predicted that by the year 2050 half of the world's population (five billion people will be myopic and that nearly one billion will be at a high risk of threatening ocular pathology. The first link between peripheral refraction and myopia, in humans, was found in 1971 by Hoogerheide and his colleagues although this issue was studied even earlier by Earl Smith 3rd using monkeys. Eye care practitioners today must not only think in terms of the short-term effect of treatment but also and more importantly, the long term effect of the treatment. Prescribing spectacles may give an immediate positive result by enabling the child to see well but this will not stop the short sightedness to progress.
Therefore we must treated children who are myopic by trying to retard the progression of the myopia. There are a number of treatments, two of which use contact lenses, either soft contact lenses or rigid gas permeable contact lenses. The treatment when using contact lenses is based on defocus at the periphery of the retina. We call this treatment pattern Myopia Control.
University of Heidelberg
Time : 09:00-09:35
Ingrid Kreissig is currently working as a Professor at the Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Germany. She did Specialization in Posterior Segment of the Eye at St. Gallen, Switzerland (1963-1965), University Eye Clinic Bonn, Germany (1965-1969) and New York Hospital-Cornell Medical Center, New York (1969-1972). She has worked as the Head of Department of Posterior Segment of the Eye at the University Eye Clinic of the Rheinische Friedrich-Wilhelms University at Bonn, Germany (1972-1979) and as Chairman of Department of Ophthalmology III (Retina and Vitreous Surgery) at the Eberhard Karls University Tuebingen, Germany (1979-2000). She has been working as an Adjunct Professor of Clinical Ophthalmology, New York Presbyterian Hospital-Cornell University, New York since 1982, Adjunct Professor of Ophthalmology, University Eye Clinic of Mannheim-Heidelberg, Germany since 2001, Representative for East Europe of EURETINA since 2002 and Professor H.C. of the Ufa Eye Research Institute, Russia since 2011. Her interests include retinal detachment surgery, diabetic retinopathy, age-related macular degeneration (AMD), posterior segment laser surgery, angiography, OCT, Medical Retina, photodynamic therapy (PDT) and application of intravitreal pharmacotherapy for various edematous and neovascular retinal/macular diseases.
The treatment options for a primary retinal detachment will be analysed by starting with Gonin in 1930 up to present in regard to their morbidity, rate of reoperation and long-term visual function. There had been a change from surgery of the entire retinal detachment to a surgery limited to the area of then retinal break and as well a change from an extraocular to an approach for reattaching the retina.
Over the last decades there had been evolved 4 major surgical techniques for repair of a primary retinal detachment being applied in the beginning of the 21st century. All of htese have still one issue in common: To find and close the retinal break which had caused the detachment and which would cause a redetachment, if not sealed off sufficiently.
Conclusion: To find and close sufficiently the break(s) in a primary retinal detachment has accompanied the efforts of retinal detachment surgeons during the past 8 decades which is still the “conditio sine qua non” for long-term reattachment. But, however, today 4 postulates have to be fulfilled for each of the 4 techniques for repair: (1) Retinal reattachment should be achieved with the 1st operation, (2) the procedure should have a minimum of morbidity, (3) it should not harbour secondary complications jeopardizing regained visual acuity and (4) it should be performed on a small budget in local anaesthesia. This is needed, because the budget for ophthalmology of today has to cover as well very expensive and long-term needed treatment modalities for AMD.